Paul M Matthews1, Valerie J Block2, Letizia Leocani3,4. 1. Department of Brain Sciences and UK Dementia Research Institute Centre, Imperial College, London, UK. 2. Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, USA. 3. University Vita-Salute San Raffaele. 4. Neurorehabilitation Department and Experimental Neurophysiology Unit, INSPE, Scientific Institute Hospital San Raffaele, Milan, Italy.
Abstract
PURPOSE OF REVIEW: To outline recent applications of e-health data and digital tools for improving the care and management of healthcare for people with multiple sclerosis. RECENT FINDINGS: The digitization of most clinical data, along with developments in communication technologies, miniaturization of sensors and computational advances are enabling aggregation and clinically meaningful analyses of real-world data from patient registries, digital patient-reported outcomes and electronic health records (EHR). These data are allowing more confident descriptions of prognoses for multiple sclerosis patients and the long-term relative benefits and safety of disease-modifying treatments (DMT). Registries allow detailed, multiple sclerosis-specific data to be shared between clinicians more easily, provide data needed to improve the impact of DMT and, with EHR, characterize clinically relevant interactions between multiple sclerosis and other diseases. Wearable sensors provide continuous, long-term measures of performance dynamics in relevant ecological settings. In conjunction with telemedicine and online apps, they promise a major expansion of the scope for patients to manage aspects of their own care. Advances in disease understanding, decision support and self-management using these Big Data are being accelerated by machine learning and artificial intelligence. SUMMARY: Both health professionals and patients can employ e-health approaches and tools for development of a more patient-centred learning health system.
PURPOSE OF REVIEW: To outline recent applications of e-health data and digital tools for improving the care and management of healthcare for people with multiple sclerosis. RECENT FINDINGS: The digitization of most clinical data, along with developments in communication technologies, miniaturization of sensors and computational advances are enabling aggregation and clinically meaningful analyses of real-world data from patient registries, digital patient-reported outcomes and electronic health records (EHR). These data are allowing more confident descriptions of prognoses for multiple sclerosis patients and the long-term relative benefits and safety of disease-modifying treatments (DMT). Registries allow detailed, multiple sclerosis-specific data to be shared between clinicians more easily, provide data needed to improve the impact of DMT and, with EHR, characterize clinically relevant interactions between multiple sclerosis and other diseases. Wearable sensors provide continuous, long-term measures of performance dynamics in relevant ecological settings. In conjunction with telemedicine and online apps, they promise a major expansion of the scope for patients to manage aspects of their own care. Advances in disease understanding, decision support and self-management using these Big Data are being accelerated by machine learning and artificial intelligence. SUMMARY: Both health professionals and patients can employ e-health approaches and tools for development of a more patient-centred learning health system.
Authors: Elisabeth Verhoeven; Philip Rouadi; Eliane Abou Jaoude; Mohamed Abouzakouk; Ignacio Ansotegui; Mona Al-Ahmad; Maryam Ali Al-Nesf; Cecilio Azar; Sami Bahna; Lyda Cuervo-Pardo; Zuzana Diamant; Habib Douagui; R Maximiliano Gómez; Sandra González Díaz; Joseph K Han; Samar Idriss; Carla Irani; Marilyn Karam; Ludger Klimek; Talal Nsouli; Glenis Scadding; Brent Senior; Pete Smith; Anahí Yáñez; Fares Zaitoun; Peter W Hellings Journal: World Allergy Organ J Date: 2022-06-23 Impact factor: 5.516
Authors: João J Cerqueira; Ana F Ladeira; Ana M Silva; Ângela Timóteo; José Vale; Lívia Sousa; Marta Arenga; Pedro Abreu; Rui Guerreiro; João de Sá Journal: Front Neurol Date: 2021-03-08 Impact factor: 4.003
Authors: Johannes Gehrig; Heinrich Johannes Bergmann; Laura Fadai; Dilara Soydaş; Christian Buschenlange; Marcus J Naumer; Jochen Kaiser; Stefan Frisch; Marion Behrens; Christian Foerch; Yavor Yalachkov Journal: Front Neurol Date: 2022-02-14 Impact factor: 4.003